BetaKine recombinant TGF-beta-2: NIH began a Phase I open-label trial

Celtrix Pharmaceuticals Inc. (CTRX), Santa Clara, Calif.

Read the full 73 word article

How to gain access

Continue reading with a
two-week free trial.